نتائج البحث - "Longen Zhou"

المساهمون: Brehmer, D., Beke, L., Wu, T., Millar, H. J., Moy, C., Sun, W., Mannens, G., Pande, V., Boeckx, A., van Heerde, E., Nys, T., Gustin, E. M., Verbist, B., Zhou, L., Fan, Y., Bhargava, V., Safabakhsh, P., Vinken, P., Verhulst, T., Gilbert, A., Rai, S., Graubert, T. A., Pastore, F., Fiore, D., Gu, J., Johnson, A., Philippar, U., Morschhauser, B., Walker, D., de Lange, D., Keersmaekers, V., Viellevoye, M., Diels, G., Schepens, W., Thuring, J. W., Meerpoel, L., Packman, K., Lorenzi, M. V., Laquerre, S.

المصدر: Molecular cancer therapeutics. 20(12)

وصف الملف: Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bff6d3af11d308608e3ab20a3144c14
https://pubmed.ncbi.nlm.nih.gov/34583982

6

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma

المؤلفون: Anand D. Jeyasekharan, Tae-Hoon Chung, Adina Huey Fang Nee, Michelle Poon, Yen Lin Chee, Joanne Lee, Wee Joo Chng, Shuangyi Fan, Esther Chan, Nurulhuda Mustafa, Sabrina Hui Min Toh, Longen Zhou, Jing Yuan Chooi, Jennifer Yang, Viknesvaran Selvarajan, Siok Bian Ng

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)

مصطلحات موضوعية: Male, 0301 basic medicine, Epstein-Barr Virus Infections, Cancer Research, Combination therapy, medicine.medical_treatment, Immunology, CD38, Lymphoma, T-Cell, Mice, 03 medical and health sciences, 0302 clinical medicine, drug evaluation, preclinical, medicine, antibodies, Animals, Humans, Immunology and Allergy, T-cell lymphoma, hematologic neoplasms, RC254-282, Pharmacology, Antibody-dependent cell-mediated cytotoxicity, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antibodies, Monoclonal, Daratumumab, Basic Tumor Immunology, Immunotherapy, medicine.disease, Lymphoma, Killer Cells, Natural, Disease Models, Animal, 030104 developmental biology, Oncology, Tumor progression, 030220 oncology & carcinogenesis, Cancer research, Molecular Medicine, Female, immunotherapy, business, neoplasm

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04be32189a30cece55511d0798b4035a
https://doi.org/10.1136/jitc-2020-002123

Find this article in full text from ProQuest

7

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

المؤلفون: Nurulhuda Mustafa, Adina Huey Fang Nee, Jennifer Yang, Viknesvaran Selvarajan, Sabrina Hui Min Toh, Longen Zhou, Jing Yuan Chooi, Wee Joo Chng, Yan Ting Hee

المصدر: Blood. 132:1663-1663

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::12ecdea5d33e0dedf46cf7485b8218cb
https://doi.org/10.1182/blood-2018-99-115566

8

A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia

المؤلفون: Heiko Konig, A. Richard Chamberlin, Wen-Hwa Lee, Chun-Mei Hu, Guideng Li, Phang Lang Chen, Erin M. Goldblatt, Xiao Long Qiu, Longen Zhou, Chi Fen Chen, Xiaoqin Lin, Ravi Bhatia, Guikai Wu, Jiewen Zhu

المصدر: EMBO Molecular Medicine
Zhu, Jiewen; Zhou, Longen; Wu, Guikai; Konig, Heiko; Lin, Xiaoqin; Li, Guideng; et al.(2013). A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Molecular Medicine, 5(3), 353-365. doi: 10.1002/emmm.201201760. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1g79t7jg

مصطلحات موضوعية: Indoles, Time Factors, RAD51, Fusion Proteins, bcr-abl, Apoptosis, Mice, SCID, Piperazines, Mice, Mice, Inbred NOD, hemic and lymphatic diseases, Tetrahydroisoquinolines, Medicine and Health Sciences, Homologous Recombination, Cml, CML, Research Articles, Cancer, Radiation, Life Sciences, Synaptonemal Complexes, Protein-Tyrosine Kinases, Tumor Burden, inhibitor, Gene Expression Regulation, Neoplastic, Molecular Docking Simulation, Mammalian-Cells, Benzamides, Imatinib Mesylate, Neoplastic Stem Cells, Molecular Medicine, Female, RNA Interference, biological phenomena, cell phenomena, and immunity, Proteasome Inhibitors, Bcr-Abl, medicine.drug, Proteasome Endopeptidase Complex, Inhibitor, small molecule, Antineoplastic Agents, Protein degradation, Biology, Transfection, Tumor-Cells, Cell Line, Tumor, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, cancer, Animals, Humans, Progenitor cell, Protein Kinase Inhibitors, Cell Proliferation, Binding Sites, Dose-Response Relationship, Drug, Cell growth, Protein, Imatinib, Small Molecule Dna-Damage Response, medicine.disease, Brc Repeats, enzymes and coenzymes (carbohydrates), Pyrimidines, Drug Resistance, Neoplasm, Cancer cell, Mutation, Rad51, Cancer research, Rad51 Recombinase, Protein Multimerization, Protein Processing, Post-Translational, Repair